Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in active colonic Crohn's disease
2006-002494-48Phase 2Terminated
- Sponsor
- University College London
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sildenafil in Crohn's disease, sponsored by University College London. Primary endpoint: Primary efficacy endpoint. Started Sep 2006; status: terminated.
02
Drugs
sildenafil
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2006-002494-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002494-48.